HighTower Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-177,637
Closed -$17.6M 2640
2019
Q3
$17.6M Sell
177,637
-42,407
-19% -$4.03M 0.1% 219
2019
Q2
$20.3M Sell
220,044
-3,223
-1% -$306K 0.12% 181
2019
Q1
$21.1M Sell
223,267
-1,534
-0.7% -$134K 0.14% 154
2018
Q4
$14.4M Sell
224,801
-87,779
-28% -$6.48M 0.11% 195
2018
Q3
$28M Buy
312,580
+74,555
+31% +$6.59M 0.2% 98
2018
Q2
$18.9M Sell
238,025
-3,329
-1% -$276K 0.15% 144
2018
Q1
$21.5M Sell
241,354
-34,398
-12% -$3.3M 0.18% 123
2017
Q4
$28.8M Sell
275,752
-13,495
-5% -$1.52M 0.24% 93
2017
Q3
$42.1M Sell
289,247
-5,177
-2% -$705K 0.36% 52
2017
Q2
$38.2M Buy
294,424
+8,305
+3% +$1.02M 0.34% 55
2017
Q1
$35.5M Buy
286,119
+53,542
+23% +$6.41M 0.34% 52
2016
Q4
$26.9M Buy
232,577
+15,346
+7% +$1.71M 0.29% 69
2016
Q3
$22.7M Buy
217,231
+4,717
+2% +$511K 0.26% 79
2016
Q2
$20.9M Sell
212,514
-61,287
-22% -$6.34M 0.27% 79
2016
Q1
$27.5M Buy
273,801
+39,238
+17% +$4.04M 0.09% 73
2015
Q4
$28.1M Buy
234,563
+16,553
+8% +$1.92M 0.33% 60
2015
Q3
$23.6M Buy
218,010
+159,688
+274% +$19.8M 0.31% 69
2015
Q2
$6.77M Sell
58,322
-109,618
-65% -$12.5M 0.11% 202
2015
Q1
$19.4M Sell
167,940
-19,452
-10% -$2.32M 0.29% 69
2014
Q4
$21M Sell
187,392
-1,288
-0.7% -$136K 0.32% 68
2014
Q3
$17.9M Buy
188,680
+21,297
+13% +$1.92M 0.3% 68
2014
Q2
$15.8M Sell
167,383
-27,247
-14% -$2.07M 0.27% 74
2014
Q1
$13.6M Sell
194,630
-21,086
-10% -$1.67M 0.26% 79
2013
Q4
$18.2M Buy
215,716
+31,856
+17% +$2.52M 0.37% 52
2013
Q3
$14.2M Sell
183,860
-3,448
-2% -$242K 0.35% 60
2013
Q2
$11M Buy
+187,308
New +$11.3M 0.3% 70

Other funds holding CELG

HighTower Advisors's CELG Position: Q4 2019 in Review

HighTower Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 177,637 shares — an estimated $17.6M sold.

HighTower Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $42.1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HighTower Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HighTower Advisors sold 177,637 Celgene Corp shares in Q4 2019, an estimated $17.6M.
  • HighTower Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • HighTower Advisors's Celgene Corp position peaked at $42.1M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.